LAL activity reduction should always be suspected in non-obese patients presenting with NAFLD and/or cryptogenic cirrhosis, unexplained persistently elevated liver transaminases or with elevation in LDL-C and decreased HDL-C (Table 1). The gene discussed is LIPA; the disease is cirrhosis, familial.